You are here

Article Text

Article menu
Download PDFPDF
Letter
Trans-Tenon’s retrobulbar triamcinolone infusion for small choroidal neovascularisation
  1. A A Okada,
  2. T Wakabayashi,
  3. E Kojima,
  4. Y Asano,
  5. T Hida
  1. Kyorin Eye Center, Kyorin University School of Medicine, 6–20–2 Shinkawa, Mitaka, Tokyo, Japan
  1. Correspondence to: A A Okada MD Department of Ophthalmology, Kyorin University School of Medicine, 6–20–2, Shinkawa, Mitaka, Tokyo 181–8611 Japan; aokadapo.iijnet.or.jp

https://doi.org/10.1136/bjo.2003.039719

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Intravitreal and sub-Tenon’s corticosteroids are being evaluated for the treatment of choroidal neovascularisation (CNV).1–3 We reported on the efficacy of triamcinolone acetonide administered as a trans-Tenon’s retrobulbar infusion (triamcinolone infusion) in reducing inflammation in uveitic eyes.4 Here we evaluated the same treatment in eyes with small subfoveal CNV.

    Case reports

    Triamcinolone infusion was performed in 22 eyes of 22 patients with subfoveal CNV of greatest diameter less than or equal to 1 disc diameter (DD). The diagnoses were age related macular degeneration (AMD) in 14 eyes, idiopathic CNV in four eyes, polypoidal choroidal vasculopathy (PCV) in three eyes, and punctate inner choroidopathy (PIC) in one eye. One AMD eye had undergone ablative argon laser photocoagulation for CNV previously, but no other eyes had received previous treatment. The median post-triamcinolone infusion follow up was …

    View Full Text